AirGo

What AirGo does

AirGo (legally MyAir, Inc.) is a privately held medical technology company headquartered in Boston with Italian operations in Milan (MyAirgo Italy Srl) that has built a 24/7 non-invasive wireless respiratory monitoring platform. The platform consists of three integrated components: the Airgo Recorder, a patented CE Class IIa certified wearable device worn around the floating ribs weighing 75 grams and capturing 6+ weeks of continuous breath-by-breath data; the Airgo app, an iOS/Android application that transfers data via Bluetooth for live and recorded monitoring sessions; and the Airgo Semantic Engine, an AI-powered analytics layer using edge computing and proprietary algorithms — including Respiratory Instability Curves (RIC) that correlate to AHI values — to deliver automated scoring, live alerts, predictive analytics, and AI-aided diagnostic reports. Validated clinical performance includes 94% positive predictive value, 89% negative predictive value, and 97.5% sensitivity for OSA detection, supported by 50,000+ hours of monitoring data across 1,100+ patients at institutions including Massachusetts General Hospital, Fondazione Maugeri, and the Minnesota Sleep Institute.

AirGo targets clinical use cases across sleep disorder screening, ICU continuous respiratory monitoring, post-operative care, remote patient monitoring, and rehabilitation. The company operates a sales-led go-to-market model through direct hospital enterprise sales, supplemented by clinical partnership-driven distribution via research collaborations. Revenue mechanics span hardware sales of the Recorder device, recurring software/analytics subscriptions for the Semantic Engine, and clinical trial services. Pricing is quote-based and not publicly disclosed, reflecting an enterprise procurement motion. The company has raised approximately €2 million in total Series A funding from HTH – Health Technology Holding and Istituti Clinici Scientifici Maugeri, and has executed strategic partnerships with Vodafone (5G telemonitoring) and Politecnico di Milano, alongside academic and clinical collaborations in both North America and Europe.

The operating footprint is geographically narrow (USA and Italy only), headcount is reported at 1–10 employees, and the company remains privately held with no IPO or acquisition activity disclosed. The latest dated milestones include CE Medical Device Class IIa certification in 2020, Covid-19 ICU deployments across four hospitals, and the 2023 publication of deep neural network sleep staging research with MGH, indicating a company that has built strong clinical and regulatory foundations but has not yet publicly demonstrated material commercial scale.

Name

AirGo

Legal name

MyAir, Inc.

Website

https://myairgo.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Short description

AirGo (MyAir, Inc.) is a Boston and Milan-based medtech company that has built a CE Class IIa certified wireless respiratory monitoring platform — combining a 75g wearable recorder, a mobile app, and an AI Semantic Engine — to deliver 24/7 breath-by-breath monitoring and automated sleep disorder screening for hospitals, sleep clinics, and ICUs.

Ownership category

akta.pro rank

Product category

Wireless Respiratory Monitoring Medical Devices

akta.pro primary industry

Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)

akta.pro secondary industries

Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Respiratory & Sleep RPM (COPD, asthma, sleep apnea) (HLALAFAB), Pulmonary Function Testing (PFT) & Respiratory Diagnostics (HLAKANAC)

Keywords

• Wireless respiratory monitoring
• Sleep apnea screening
• Continuous respiratory monitoring
• Wearable medical device
• Respiratory diagnostic platform

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others

Revenue model

1. Medical Device Sales: Sale of Airgo Recorder hardware device - CE Class IIa certified hospital-grade respiratory recorder sold to healthcare institutions including hospitals, sleep clinics, and rehabilitation centers.
2. Software Analytics Platform: Airgo Semantic Engine software providing AI-powered respiratory analytics, automated scoring, predictive alerts, and diagnostic reports. Sold as part of the platform or as ongoing service.
3. Clinical Trial Services: Research collaboration and clinical trial services conducted with hospital partners for validation studies.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

AirGo provides a 24/7 non-invasive wireless respiratory monitoring platform comprising a CE Class IIa certified 75-gram wearable recorder (Airgo Recorder), a Bluetooth companion mobile app (Airgo app), and an AI-powered analytics platform (Airgo Semantic Engine) that captures continuous breath-by-breath data, automates sleep-disorder scoring, and delivers predictive alerts for use by hospitals, sleep clinics, ICUs, and rehabilitation centers.

Product overview

AirGo offers a unified 24/7 non-invasive wireless respiratory monitoring platform comprising three integrated products: the Airgo Recorder (a CE Class IIa certified wearable device worn on the chest that captures breath-by-breath biometric data), the Airgo app (iOS/Android mobile application enabling Bluetooth data transfer and session management), and the Airgo Semantic Engine (AI/ML analytics platform that processes raw respiratory data into automated scoring, predictive alerts, and diagnostic reports). The platform is designed for clinical use in sleep disorder screening, hospital monitoring, and remote patient care.

Differentiator

Problem solved

Functional benefit

Products and services

• Airgo Recorder A patented, CE Class IIa certified hospital-grade wearable medical device worn around the floating ribs. Weighs 75 grams, captures 6+ weeks of continuous data with 3 weeks battery autonomy. Measures Respiratory Rate (RR), Relative Tidal Volume (Vt), Relative Minute Ventilation (Mv), Inhalation/Exhalation Time (Ti/Te), Functional Residual Capacity (FRC), Posture and Activity, Sleep Staging, and periodic breathing patterns (Cheyne-Stokes, Kussmaul, Apnea). Sold to hospitals, sleep disorder clinics, and rehabilitation centers.
• Airgo app Companion mobile application for iOS and Android that communicates via Bluetooth (BLE) with the Airgo Recorder. Transfers biometric data for live and recorded monitoring sessions of patients in daily activity, hospital, and home settings.
• Airgo Semantic Engine AI-powered analytics platform using edge computing and proprietary algorithms that processes biometric data to provide respiratory trend analytics, live alerts, AI-aided diagnostic reports, and proprietary Respiratory Instability Curves (RIC) that correlate to industry-standard AHI values. Includes automated sleep disorder detection (OSA, CSA, Cheyne-Stokes, AHI/RDI scoring) and deep neural network ICU sleep staging (co-developed with Massachusetts General Hospital). Sold as part of the platform with recurring subscription.

Quantifiable outcome

• 94% positive predictive value and 89% negative predictive value for obstructive sleep apnea (OSA) detection
• +5 more outcomes

Named customers7 records

Segments7 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core, major and minor.

• Massachusetts General Hospital (MGH)coreStrategic or Co-development PartnerClinical research partnership for sleep staging in ICU using deep neural networks. MGH conducted sleep scoring validation vs PSG Gold standard (400+ patients, 2018). High prevalence of sleep disordered breathing study published in Sleep and Breathing journal.
• Fondazione Maugeri IRCCS VerunocoreStrategic or Co-development PartnerClinical research partnership for sleep monitoring validation (150+ patients, 2019). Device clinically tested at Maugeri for World Sleep Day screening programs. Ongoing collaboration for Covid-19 monitoring and respiratory disorder studies.
• Minnesota Sleep InstitutecoreStrategic or Co-development PartnerClinical validation partnership for sleep scoring vs PSG Gold standard (60+ patients, 2015). Early partner in clinical validation of Airgo platform.
• Ospedale Santa Croce e Carle CuneocoreStrategic or Co-development PartnerClinical validation partnership for spirometry monitoring (21 patients) and comparison with metabolic cart. Validation study published in Sensors journal (2020) showing Airgo precision at rest and exercise.
• Ospedale San Raffaele (Milan)majorStrategic or Co-development PartnerClinical research partnership for respiratory monitoring studies in Milan, Italy.
• Politecnico di MilanocoreStrategic or Co-development PartnerAcademic research partnership for wearable respiratory monitoring technology development. Published comparison of Airgo and metabolic cart signals. Collaborated on 5G telemonitoring system with Vodafone.
• VodafonemajorTechnology or Integration5G telemonitoring trial partnership for home telemedicine system for continuous respiratory monitoring. Vodafone 5G infrastructure incorporated into Airgo platform for home patient monitoring.
• Elite Athletic CoachesminorStrategic or Co-development PartnerCollaborations with elite athletic coaches where strategic breathing is key to performance. These collaborations contribute to understanding of respiratory dynamics across the full spectrum.
• AIPO (Associazione Italiana Pneumologi Ospedalieri)majorGTM or Marketing PartnerItalian Association of Hospital Pneumologists - conducted webinar on March 25, 2021 titled 'Cattura il respiro / Catch your breath' featuring Airgo device and diagnostic paths for sleep disorder screening.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Nox Medical: Nox Medical develops wearable sleep diagnostic and respiratory monitoring devices (Noxturnal, T3 device), directly comparable to Airgo's wireless respiratory recorder and software analytics stack for sleep labs and home sleep testing.
• SOMNOmedics: SOMNOmedics manufactures portable polysomnography and respiratory monitoring systems (SOMNOwatch, SOMNOscreen) used in sleep medicine and cardiology — a direct competitor in clinical-grade wireless respiratory and sleep monitoring.
• Compumedics: Compumedics supplies sleep diagnostics, EEG, and respiratory monitoring hardware (Siesta, Grael) to sleep labs and hospitals worldwide, comparable to Airgo's clinical sleep screening and respiratory monitoring offering.
• Itamar Medical (WatchPAT): Itamar Medical's WatchPAT is a wearable home sleep apnea test using peripheral arterial tone signals — a direct competitor in the simplified, ambulatory OSA diagnostic category that Airgo also targets.
• Cidelec: Cidelec designs ambulatory sleep apnea screening and respiratory monitoring devices (CID-LXe, Pneumotel) used by sleep centers and occupational health providers — a direct competitor in the wireless OSA screening and respiratory monitoring category.
• COSMED: COSMED manufactures cardiopulmonary and metabolic diagnostic equipment including wearable indirect calorimetry and spirometry (K5, Quark), comparable to Airgo's respiratory monitoring and pulmonary function validation work.

Broad incumbents

• ResMed: ResMed is the global leader in sleep apnea therapy and connected respiratory care, with a broad portfolio spanning CPAP devices, masks, and digital health — an incumbent whose sleep diagnostics and connected-health efforts compete broadly with Airgo's screening and RPM platform.
• Philips Respironics: Philips Respironics is a major incumbent in sleep apnea diagnosis and therapy, with Alice PSG systems and a broad hospital respiratory monitoring portfolio — a broad incumbent competing with Airgo across sleep labs and hospital respiratory monitoring.
• Vyaire Medical: Vyaire Medical is a broad incumbent in respiratory diagnostics and ventilation, with spirometry and pulmonary function products overlapping with Airgo's clinical respiratory monitoring and pulmonary assessment capabilities.

Emerging players

• Spire Health: Spire Health produces a wearable respiratory monitoring patch for continuous lung function tracking, comparable to Airgo's wireless respiratory recorder — overlapping in home-based continuous respiratory monitoring use cases.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/myair-inc

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AirGo